Trial Details

COMPLETED
Basic Information
Clinical ID c4186
Identifier NCT00918411
Trial Title A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome
Interventions DRUG: Ramosetron|DRUG: Placebo
Participant Information
Sponsor Astellas Pharma Inc
City Hokkaido
Country/Region Japan
Enrollment Criteria
Sex Requirement MALE
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2009-06
Primary Completion Date 2009-12
Completion Date 2009-12